Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.

Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.

There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Genki Hayashi, Gino Cortopassi
Fformat:	Erthygl
Iaith:	English
Cyhoeddwyd:	Public Library of Science (PLoS) 2016-01-01
Cyfres:	PLoS ONE
Mynediad Ar-lein:	http://europepmc.org/articles/PMC4831832?pdf=render

Eitemau Tebyg

Sexual dimorphism in a mouse model of Friedreich’s ataxia with severe cardiomyopathy
gan: Lili Salinas, et al.
Cyhoeddwyd: (2024-10-01)

Potential biomarker identification for Friedreich's ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion.
gan: Marissa Z McMackin, et al.
Cyhoeddwyd: (2019-01-01)

Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.
gan: Mittal Jasoliya, et al.
Cyhoeddwyd: (2019-01-01)

Genetics and Friedreich Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (2002-06-01)

Genetics of Friedreich Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (1997-06-01)

Friedreich’s Ataxia: A Neuronal Point of View on the Oxidative Stress Hypothesis
gan: Barbara Carletti, et al.
Cyhoeddwyd: (2014-09-01)

Molecular Defects in Friedreich’s Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities
gan: Frances M. Smith, et al.
Cyhoeddwyd: (2020-11-01)

Late-Onset Friedreich’s Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (1993-08-01)

Friedreich’s Ataxia with Retained Reflexes
gan: J Gordon Millichap
Cyhoeddwyd: (1995-04-01)

Friedreich's Ataxia and Glucose Metabolism
gan: J Gordon Millichap
Cyhoeddwyd: (1988-08-01)

5-Hydroxytryptophan in Friedreich’s Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (1995-06-01)

Iron Storage in Friedreich’s Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (1999-08-01)

Tissue Iron in Friedreich Ataxia
gan: Arnulf H Koeppen
Cyhoeddwyd: (2024-01-01)

Respiratory Function in Friedreich’s Ataxia
gan: Elena Vinante, et al.
Cyhoeddwyd: (2022-08-01)

The pathogenesis of cardiomyopathy in Friedreich ataxia.
gan: Arnulf H Koeppen, et al.
Cyhoeddwyd: (2015-01-01)

Is Friedreich ataxia an epigenetic disorder?
gan: Kumari Daman, et al.
Cyhoeddwyd: (2012-01-01)

Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
gan: Vilema Enriquez, MG
Cyhoeddwyd: (2018)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
gan: Cheick A. K. Cissé, et al.
Cyhoeddwyd: (2021-05-01)

Advantages and Limitations of Gene Therapy and Gene Editing for Friedreich’s Ataxia
gan: Anusha Sivakumar, et al.
Cyhoeddwyd: (2022-05-01)

Antioxidant Therapies and Oxidative Stress in Friedreich’s Ataxia: The Right Path or Just a Diversion?
gan: Laura R. Rodríguez, et al.
Cyhoeddwyd: (2020-07-01)

Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia.
gan: Vincent Paupe, et al.
Cyhoeddwyd: (2009-01-01)

Exploring neuropsychiatric symptoms in Friedreich ataxia
gan: Simona Karamazovova, et al.
Cyhoeddwyd: (2024-11-01)

Friedreichs ataxia in a diabetic patient
gan: Inna Igorevna Klefortova, et al.
Cyhoeddwyd: (2010-06-01)

Friedreich's Ataxia – A Clinical Diagnosis
gan: Md. Fekarul Islam, et al.
Cyhoeddwyd: (2015-01-01)

Clinical and Genetic Diagnosis of Friedreich’s Ataxia
gan: J Gordon Millichap
Cyhoeddwyd: (1998-05-01)

Emerging antioxidant therapies in Friedreich’s ataxia
gan: Fred Jonathan Edzeamey, et al.
Cyhoeddwyd: (2024-02-01)

An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
gan: Riccardo Turchi, et al.
Cyhoeddwyd: (2020-10-01)

Perspectives on current models of Friedreich’s ataxia
gan: Simge Kelekçi, et al.
Cyhoeddwyd: (2022-08-01)

Anaesthesia for a patient with Friedreich′s ataxia
gan: Ilango Ganesan
Cyhoeddwyd: (2011-01-01)

Otoneurological Abnormalities in Patients with Friedreich's Ataxia
gan: Bianca Simone Zeigelboim, et al.
Cyhoeddwyd: (2017-01-01)

Epigenetic-based therapies for Friedreich ataxia
gan: Chiranjeevi eSandi, et al.
Cyhoeddwyd: (2014-06-01)

Predictors of loss of ambulation in Friedreich's ataxia
gan: Christian Rummey, et al.
Cyhoeddwyd: (2020-01-01)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
gan: Stüwe Sven H, et al.
Cyhoeddwyd: (2011-11-01)

Prediction of the disease course in Friedreich ataxia
gan: Christian Hohenfeld, et al.
Cyhoeddwyd: (2022-11-01)

Friedreich’s Ataxia-A Case Report
gan: Tahreem Muntaha, et al.
Cyhoeddwyd: (2018-11-01)

Friedreich ataxia- pathogenesis and implications for therapies
gan: Martin B. Delatycki, et al.
Cyhoeddwyd: (2019-12-01)

At-home wearable-based monitoring predicts clinical measures and biological biomarkers of disease severity in Friedreich’s Ataxia
gan: Ram Kinker Mishra, et al.
Cyhoeddwyd: (2024-10-01)

Perspectives of the Friedreich ataxia community on gene therapy clinical trials
gan: Shandra J. Trantham, et al.
Cyhoeddwyd: (2024-03-01)

Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.
gan: Timothy E Richardson, et al.
Cyhoeddwyd: (2012-01-01)

Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich’s Ataxia Models
gan: Rosella Abeti, et al.
Cyhoeddwyd: (2018-07-01)